VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1522218
Sex: F
Age:
State: TN

Vax Date: 04/11/2021
Onset Date: 04/13/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Vomitting; diarrhea; body aches; fever; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ER2613), via an unspecified route of administration in the left arm on 11Apr2021 at 17:00 (at the age of 25-year-old), dose 1, single for COVID-19 immunisation. The patient had no medical history. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), mirtazapine (REMERON), aripiprazole (ABILIFY), paracetamol (TYLENOL), and ethinylestradiol, levonorgestrel (FALMINA). The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. The vaccine was administered at pharmacy or drug store. On 13Apr2021 at 04:00, the patient experienced vomiting, diarrhea, body aches, fever. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was recovered. No follow-up attempts are possible; No further information is expected.

Other Meds: EFFEXOR; REMERON; ABILIFY; TYLENOL; FALMINA

Current Illness:

ID: 1522219
Sex: F
Age:
State: NC

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: chills; fever; muscle aches (entire body).; This is a spontaneous report from a contactable consumer. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955), via an intramuscular route of administration in the right arm on 07Apr2021 at 08:00 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. Medical history included seasonal allergies and insomnia. Concomitant medications included trazadone 100 mg SID (MANUFACTURER UNKNOWN) and levocetirizine SID (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247), via an intramuscular route of administration in the right arm on 17Mar2021 at 08:00 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. On 07Apr2021 at 23:30, 14 hours post injection, the patient experienced chills, fever and muscle aches (entire body). On an unspecified date, the patient received oral TYLENOL as needed as treatment for the adverse events. The clinical outcomes of the events chills, fever and muscle aches (entire body) was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: TRAZODONE; LEVOCETIRIZINE

Current Illness:

ID: 1522220
Sex: F
Age:
State: SC

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: spiked a fever of 103.5/lasted 3 days; had a severely painful and swollen lymph node under my left armpit; had a severely painful and swollen lymph node under my left armpit; pain all over my body; nauseous; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot unknown, second dose) solution for injection intramuscular in the left arm on 01May2021 at 16:30 (at the age of 30-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included pulmonary embolism, foot surgery, shoulder surgery, hypothyroidism, and allergy: dates. Concomitant medications included levothyroxine sodium (SYNTHROID), citalopram, cetirizine hydrochloride (ZYRTEC) and colecalciferol (VITAMIN D). Past drug history included known allergy: vancomycin. Historical vaccine included BNT162B2 (first dose) for COVID-19 vaccination on 10Apr2021 with no adverse effect reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 01May2021 at 07:30 PM, the patient spiked a fever of 103.5 F, lasted 3 days (went down briefly after taking OTC medication), had a severely painful and swollen lymph node under my left armpit, pain all over my body, and nauseous. The events resulted in an emergency room/department or urgent care visit. Treatment for the events included taking over the counter (OTC) medication and fluids. The outcome of the events was recovered with sequel in May2021. Since the vaccination, the patient has not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: SYNTHROID; CITALOPRAM; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; VITAMIN D

Current Illness:

ID: 1522221
Sex: M
Age:
State: WI

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Joint pains just about everywhere that have not diminished. Both wrists get so sore he can barely use hands after any major activity. Also neck, back, hands fingers, and some previously injured areas are affected too; sore neck, back, hands fingers, and some previously injured areas are affected too.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161), via an unspecified route of administration in the left arm on 04May2021 at 09:30 (at the age of 57-year-old), as a single dose for COVID-19 immunisation. Medical history included heart/vascular disorder, asthma, arthritis and migraine. The patient received unspecified medications within two weeks of vaccination. The patient past drug history included ACE inhibitors on an unknown date for an unknown indication and the patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6209), via an unspecified route of administration on an unknown date (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient had been tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 01:00, the patient experienced joint pains just about everywhere that have not diminished, both wrists had got so sore the patient barely use hands after any major activity, also neck, back, hands fingers, and some previously injured areas were affected too. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event joint pains just about everywhere that have not diminished, both wrists had got so sore the patient barely use hands after any major activity, also neck, back, hands fingers, and some previously injured areas were affected too was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522222
Sex: F
Age:
State: CA

Vax Date: 05/02/2021
Onset Date: 05/03/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Mild fever; Swollen Lymph node under armpit on the same arm as injection site; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 02May2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included multi vitamins (MANAFACTURER UNKNOWN), birth control (MANAFACTURER UNKNOWN) all from an unknown date. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 12Apr2021 at 15:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 06:00 the patient experienced mild fever, swollen lymph node under armpit on the same arm as injection site. The clinical outcome of the events fever, swollen lymph nodes was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522223
Sex: F
Age:
State: CA

Vax Date: 04/30/2021
Onset Date: 05/01/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Fast heart beat; Felt like I slept the whole day away; Dizziness; Weak forearms and calves; Soreness of injection site, sore/weak; Tingling forearms and calves; Sore forearms and calves; Fatigue; Slight nausea; General malaise; Headache; Not too sure if I had a fever, but it definitely felt like I did.; This is a spontaneous report from a contactable consumer, the patient. A 29-years-old pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the right arm on 30Apr2021 at 13:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included generalised anxiety disorder. The patient had known allergic to some perfumes, dyes and was lactose intolerant. The patient received concomitant medications metoprolol succinate (MANUFACTURER UNKNOWN) 25mg and Womens 1 A Day daily multivitamin (MANUFACTURER UNKNOWN) for unknown indications, from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 i.e. next day after 2nd dose at 02:00, the patient experienced intense side effects like soreness of injection site, sore/weak and tingling forearms and calves, fatigue, dizziness, slight nausea, general malaise and headache. The patient was not too sure if had a fever (she did not have a temperature checker), but definitely felt like had fever. The day after (02May2021) was the worst of the symptoms and it persisted for an additional 3 more days. Though her symptoms did gradually decrease in severity, it was very unusual and scary for patient. The patient really did not feel well or like herself. Day one and two after 2nd dose (01May2021), the patient felt like she slept the whole day away due to which also called sick to work. The soreness in forearms and calves were usual but they felt very weak the first two days and the third and last day (at the time of this report) felt tingly. The headaches, fatigue, and malaise were there till end. Though patient was awaken this morning (05May2021) around 9 am to very fast heart beat due to which patient had to take metoprolol succinate 25mg medication early. Therapeutic measure was taken for fast heart beat which included metoprolol succinate 25mg. The clinical outcome of the event soreness of injection site, weak forearms and calves, tingling forearms and calves, sore forearms and calves site, fatigue, dizziness, slight nausea, general malaise, fever, headache, felt like slept the whole day away and fast heart beat was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: METOPROLOL SUCCINATE

Current Illness:

ID: 1522224
Sex: F
Age:
State: IN

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Barking cough; Getting sick easier; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history included asthma, hypothyroidism, and obesity. The patient was intolerant to lactose. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 01Apr2021, about 12-15 hours after 1st dose, the patient experienced barking cough, was getting sick easier than she ever had before and she got sicker than other people with similar bugs. The patient stated, it was like her immune system didn't work. The event barking cough was still continuing at the time of this report. On 21Apr2021, the patient underwent nasal swab test and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event barking cough which included treatment with cough medicine. The clinical outcomes of barking cough and getting sick easier were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522225
Sex: F
Age:
State: MA

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Bone and joint pain from neck to toes; Bone and joint pain from neck to toes; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 09:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included escitalopram (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 09:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient previously received paracetamol; oxycodone hydrochloride (PERCOCET) for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04May2021 at 21:30, the patient experienced bone and joint pain from neck to toes. The clinical outcome of the events bone and joint pain from neck to toes were resolving at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ESCITALOPRAM

Current Illness:

ID: 1522226
Sex: F
Age:
State: FL

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Severe Muscle Aches day after second injection; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0170) via an unspecified route of administration in the right arm on 03May2021 15:45 hours (at the age of 50-year-old) as a single dose for COVID-19immunisation. Medical history was not reported. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), sertraline hydrochloride (ZOLOFT), zolpidem tartrate (AMBIEN) and alprazolam (XANAX) and LOMICTAL all for unknown indication, from an unknown date. The past medication history include sulfadiazine (SULFA) for unknown indication on an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0158) via an unspecified route of administration in the right arm on 12Apr2021 15:45 hours as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four week of vaccination. On 04May2021 at 07:00 the patient experienced severe muscle aches day after second injection. The clinical outcome of the event severe muscle aches day was recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT; AMBIEN; XANAX; ADDERALL

Current Illness:

ID: 1522227
Sex: F
Age:
State: RI

Vax Date: 04/25/2021
Onset Date: 04/25/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Burning sensation in neck for 24 hours tapered slowly.; Back pain.; Sore armpits for 1 week; Tender breast for 1 week; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 25Apr2021 at 14:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included bell's palsy on left side 2 years ago and the patient was still dealing with synkinesis. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Apr2021 at 14:45, the patient experienced burning sensation in neck for 24 hours tapered slowly, back pain, sore armpits and tender breast for 1 week. The clinical outcome of the events burning sensation in neck for 24 hours tapered slowly, back pain, sore armpits and tender breast for 1 week was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522228
Sex: F
Age:
State: PA

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Severe abdominal pain; Vomited; I felt kind of yucky; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 26Mar2021 at 11:30 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic pancreatitis hypoglycemia due to type 1 diabetes mellitus. Concomitant medications included insulin (MANUFACTURER UNKNOWN), pancreatin (CREON), pantoprazole sodium sesquihydrate (PROTONIX) and vitamin d nos (VITAMIN D) all taken on unknown date, for unknown indication. The patient previously took boric acid (MANUFACTURER UNKNOWN), ibandronate sodium (BONIVA), fluconazole (DIFLUCAN) all for unknown indication, from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 05Mar2021 at 11:00 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 Saturday, one day after the vaccination, the patient felt kind of yucky, but ate small meals. On Saturday night at 1900 the patient started feeling severe abdominal pain and double over. The patient sat down with feet up hoping it would subside but it didn't, it got worsened. On 22:20, the patient was in the bathroom hoping to go but not much would come out, patient did throw up. Since in 19 years, first time the patient brought up mostly flem and specs of food. After that, patient reported that some of the pain went away but it continued on Sunday 28Mar2021, but the patient did not have any vomiting. The clinical outcome of the events felt yucky (nausea) was unknown and severe abdominal pain was recovering at the time of this report. The clinical outcome of the event vomiting was recovered on 28Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: INSULIN; VITAMIN D NOS; CREON; Protonix

Current Illness:

ID: 1522229
Sex: F
Age:
State: CT

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Arm pit swollen gland; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 10Apr2021 at 13:30 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy. Concomitant medications included topiramate (TOPAMAX), lacosamide (VIMPAT), clonazepam (MANUFACTURER UNKNOWN), lamotrigine (MANUFACTURER UNKNOWN) and buspirone (MANUFACTURER UNKNOWN). The patient previously took shellfish and drugs which included penicillin and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 the patient experienced arm pit swollen gland. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event arm pit swollen gland was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: TOPAMAX; VIMPAT; CLONAZEPAM; LAMOTRIGINE; BUSPIRONE

Current Illness:

ID: 1522230
Sex: M
Age:
State: CT

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: I have had a fever on and off for 8 days since the second shot. It comes and goes but I can't shake being sick.; I have had a fever on and off for 8 days since the second shot. It comes and goes but I cant shake being sick.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 14:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient previously had taken apple skins and Debrox from unknown date to unknown date for unknown indication. Concomitant medications taken within two weeks prior to vaccination included cetirizine hydrochloride (ZYRTEC), escitalopram oxalate (LEXAPRO) and montelukast sodium (SINGULAIR) started on unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 15:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 22:00, the patient had a fever on and off for 8 days since the second shot. It came and went but he could not shake being sick. The event resulted in doctor or other healthcare professional office/clinic visit. On 05May2021, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the event fever and being sick was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Zyrtec; LEXAPRO; SINGULAIR

Current Illness:

ID: 1522231
Sex: M
Age:
State: WA

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Administered 0.5 mL of vaccine, not 0.3 mL; This is a spontaneous report from a contactable other healthcare professional. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration of 0.5 ml in the left arm on 08Apr2021 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 08Apr2021, the patient was administered 0.5 mL of vaccine and not 0.3 mL (inappropriate dose of vaccine administered). The clinical outcome of the event inappropriate dose of vaccine administered was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522232
Sex: M
Age:
State:

Vax Date: 04/30/2021
Onset Date: 05/02/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Random red and pink dots appeared around body on face, abdomen, chest, stomach, armpit, nipple; Slight itchy; Slightly itchy, not painful, except for nipple and armpit areas.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 30Apr2021 at 11:30 as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included cetirizine hydrochloride (ZYRTEC) for unknown indications from an unspecified date. The patient's past drug history was reported as none. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 22:00, after 48 hours of receiving the vaccine, the patient developed random red/pink dots around the body, on face, abdomen, chest, stomach, armpit and nipple. It was slightly itchy not painful except for nipple and armpit areas. It was similar to deep pimple in pain and sensitivity. The red spots had slow growth and spread of some spots on abdomen and neck. The clinical outcome of the events rash all over, itchy rash and painful rash were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Zyrtec

Current Illness:

ID: 1522233
Sex: F
Age:
State: TX

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Mild fatigue; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 04May2021 at 10:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 13Apr2021 at 10:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 11:00, the patient experienced mild fatigue relieved by rest. The clinical outcome of the event mild fatigue was recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522234
Sex: F
Age:
State:

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Soreness/pain in left arm at the injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 26Apr2021(at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Apr2021, the patient experienced Soreness/pain in left arm at the injection site. The clinical outcome of the event Soreness/pain in left arm at the injection site was recovered on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1522235
Sex: F
Age:
State: MN

Vax Date: 04/22/2021
Onset Date: 04/25/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: constant, low volume buzzing, whistling in my head. Tinnitus? Didn't start until after second vaccine. Has not changed in freguency or intensity as of this reporting.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the arm left on 22Apr2021 at 14:30 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient received unspecified medication within two weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 01Apr2021 at 08:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation and penicillin and nickel on unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Apr2021 at 20:00 after the second vaccination, the patient experienced constant, low volume buzzing, whistling in my head. Tinnitus? Has not changed in frequency or intensity as of this reporting. The clinical outcome of the event ear buzzing was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522236
Sex: M
Age:
State: TX

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Extreme pain in the left stomach and back; Extreme pain in the left stomach and back; Extreme pain in the chest and abdomen area; Extreme pain in the chest and abdomen area; Vaccinated arm got a lot of muscle soreness; Fever; Heart beat so fast; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8727) via an unspecified route of administration in the arm left on 24Apr2021 at 12:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any other medications within two weeks of COVID-19 vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in 2021, the patient experienced heart beat so fast and fever. On 24Apr2021, the patient experienced muscle soreness of vaccinated arm and about 6 days later, arm was no longer have any soreness. On 30Apr2021 (on 6th day) the patient got extreme pain in the chest and abdomen area. It was reported that, it was happened when the patient was sleeping. It was so painful that the patient had to wake up in the middle of the night. The patient cannot even lie down on the bed. On the 8th day, chest and abdomen pain went away. On an unknown date in May2021, the patient got extreme pain in the left stomach and back and it was still painful. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event muscle soreness was recovered on an unknown date in Apr2021, while that of extreme pain in the chest and abdomen area was recovered on 02 May2021. The clinical outcome of the event extreme pain in the left stomach and back was not recovered while the clinical outcome of the events heart beat so fast and fever were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522237
Sex: M
Age:
State: FL

Vax Date: 04/26/2021
Onset Date: 04/01/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: He started to feel weak to a point that he felt was going to pass out; He started to feel weak to a point that he felt was going to pass out; Fell three times; His legs were completely numbed; He suffered a cut in one of his knees; Bruises on the shoulders; Limping from his injuries; This is a spontaneous report from a contactable consumer (patient's grand parent). A 22-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 26Apr2021 (at the age of 22-years-old) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 26Apr2021, the patient experienced he started to feel weak to a point that he felt was going to pass out, he started to feel weak to a point that he felt was going to pass out, fell three times, his legs were completely numbed, he suffered a cut in one of his knees, bruises on the shoulders and on Apr2021 limping from his injuries. Reportedly, he was not asked to wait for at least 15 minutes. Unaware of any possible reaction, he left the store immediately and drove away. On his way, he started to feel weak to a point that he felt was going to pass out. He doesn't remember how he came to stop the car. At one point, he stepped out of the car on a huge avenue, fell three times as his legs were completely numbed. He suffered a cut in one of his knees, bruises on the shoulders. A couple that was driving by him noticed he was in trouble, stopped and helped him. They gave him water and called the paramedics came in and checked his vitals. Found his vitals ok and released him to get back to our home. I contacted the pharmacy headquarters the day after. They told me they were going to contact him soon, which it has not happened. They made a note of my report as reference. The name of the person I spoke to was I insisted they also contacted the store and let them know of the incident, as in my view didn't follow the expected protocol and put him at risk of a fatal accident. Outcome of the event limping from his injuries was not recovered and for other events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522238
Sex: F
Age:
State: CA

Vax Date: 04/29/2021
Onset Date: 04/30/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Sore throat; Cough; Chills; Headache; Body aches; Joint pain; Arm pain; Swollen lymph node (left under arm), Swollen lymph nodes in neck; Fever; Severe fatigue; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Ew0172), via an unspecified route of administration in left arm on 29Apr2021 at 16:00 (at the age of 39-year-old) at single dose for COVID-19 immunisation. Medical history included asthma, depression and insomnia/sleep disorder. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), fexofenadine hydrochloride (ALLEGRA ALLERGY), mometasone furoate (FLONASE) and vitamin D. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: ER8729) via an unspecified route of administration in left arm on 08Apr2021 at 16:00 (at the age of 39-year-old) at single dose for COVID-19 immunisation; iodine and experienced drug allergy. On 30Apr2021 at 20:00, the patient experienced chills, headache, body ache, joint pain, arm pain, swollen lymph node (left under arm), swollen lymph nodes in neck, fever (99-101 while taking paracetamol (TYLENOL)), severe fatigue. Started on 02May2021, patient experienced sore throat and cough, continued fatigue, continued fever, swollen lymph nodes in neck. As of 05May2021, sore throat, cough, fatigue, swollen lymph nodes in neck and fever were still present. Cough had worsened. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as result of fever included paracetamol (TYLENOL). No treatment was received for the other events. The clinical outcome of the events sore throat, cough, fatigue, swollen lymph nodes in neck and fever was not recovered, outcome of the other events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO; ALLEGRA ALLERGY; FLONASE [MOMETASONE FUROATE]; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1522239
Sex: F
Age:
State: CA

Vax Date: 03/03/2021
Onset Date: 03/13/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: My skin start infection rash.; My skin start infection rash, itching, stining, all over my neck, ear, face and arm,; My skin start infection rash, itching, stining, all over my neck, ear, face and arm,; My skin start infection rash, itching, stining, all over my neck, ear, face and arm,; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 03Mar2021 at 10:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient's past drug history was reported as unknown. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 13Mar2021 at 08:00, the patient experienced skin infection with rash, itching, stinging all over neck, ear, face, arm and was very painful. The event resulted in emergency room/department or urgent care. The clinical outcome of the events skin infection, rash, itching and stinging were not resolved at the time of this report. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522240
Sex: F
Age:
State: DC

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: bright yellow rash or bruising lasting for a few hours on non-vaccinated arm; Vaccinated arm significantly colder than the other arm; Numbing of vaccinated right arm, then right leg, then left leg hour; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 18:00 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). Concomitant medications included levonorgestrel (MIRENA) from an unknown date taken for birth control. Prior to the vaccination, it was unsure if the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 21Apr2021, the patient underwent PCR test and the result was negative. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient experienced numbing of vaccinated right arm, then right leg, then left leg hour after vaccination for several hours after vaccination. Next day (17Apr2021), vaccinated arm significantly colder than the other arm. On 04May2021, the patient experienced bright yellow rash or bruising lasting for a few hours on non-vaccinated arm. The clinical outcome of the events of numbness and coldness was recovered on an unknown date in Apr2021 while the clinical outcome of the event of bruising of arm was recovered on 04May2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: MIRENA

Current Illness:

ID: 1522241
Sex: M
Age:
State: WA

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Administered 0.5 mL of vaccine, not 0.3 mL; This is a spontaneous report from a contactable healthcare professional. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 08Apr2021 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 08Apr2021, the patient was administered 0.5 mL of vaccine, not 0.3 mL (inappropriate dose of drug administered). The clinical outcome of the event administered 0.5 mL of vaccine, not 0.3 mL (inappropriate dose of drug administered) was resolved at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522242
Sex: M
Age:
State: CA

Vax Date: 03/08/2021
Onset Date: 03/09/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Soreness in the arm at shot area; Fatigue; feverish; This is a spontaneous report from a contactable consumer, the patient. An 67-year-old male patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 08Mar2021 at 13:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient no known allergies. The patient did not receive any medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Mar2021, day after the shot in the morning, the patient felt symptoms of soreness in the arm at shot area, fatigue and feverish, one day after shot was administered. The patient was fine till the symptoms started. The clinical outcome of the event soreness in the arm at shot area, fatigue and feverish were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522243
Sex: F
Age:
State: CA

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Rt arm site of administered very COLD / Cool to touch; Normal hurt/ discomfort; Nausea; Frontal headache; lightheaded; strange sensation of NUMBNESS started exterior side of right thumb & rt thumb pad. Numbness moved to involve entire rt thumb. Numbness to lesser degree tip to palm of rt index finger rt middle finger, rt ring finger & rt pinkie.; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0173) via an unspecified route of administration in the right arm on 04May2021 at 10:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Medical history included long term chronic autoimmune diseases and syndrome and on &off sensitive reactions. Concomitant medications included estradiol (ESTRADIOL TRANSDERMAL SYSTEM) and fentanyl (MANUFACTURER UNKNOWN), all for unknown indication from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153), via an unspecified route of administration in the right arm on 13 Apr2021 at 10:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 10:00, the patient experienced numbness, On 05May2021 the patient experienced nausea, discomfort, frontal headache, lightheaded and feeling cold. It was reported that within few minutes of 2nd Dose administered, strange sensation of NUMBNESS started exterior side of right thumb and rt thumb pad. Numbness moved to involve entire rt thumb. Numbness to lesser degree tip to palm of rt index finger rt middle finger, rt ring finger & rt pinkie. Almost immediately started flexing massaging and moving thumb & fingers Made certain to keep right arm moving/ in motion Rt fingers hand wrist arm flexed massaged moved. On & off for hours. Rt thumb remains semi numb on 05/05/2021. Numbness diminished in rt fingers, but semi numb rt finger tips. Failed to tell. Messaged online care provider & Pfizer on 05/05/2021. NOTE: Rt arm site of administered Pfizer 2 Dose very COLD / Cool to touch for 24+ hours. Normal hurt/ discomfort. Less than 60 after Pfizer 2 started normal/ common side effects...Nausea, frontal headache, lightheaded History of long-term autoimmune disease & syndromes. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of numbness, nausea, discomfort, frontal headache, lightheaded and feeling cold was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: ESTRADIOL TRANSDERMAL SYSTEM; FENTANYL

Current Illness:

ID: 1522244
Sex: F
Age:
State: MO

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Felt like baseball in left armpit, very sore; Felt like baseball in left armpit, very sore; Taste sensation like Sucrets on the tongue; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 15Apr2021 at 11:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, penicillin allergy and sulfonamide allergy(sulfa). Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) for unknown indication and from an unspecified date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 26Mar2021at 13:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient experienced immediate taste sensation like sucrets on the tongue for 5-10 min. On 18Apr2021, 2 days later the patient felt like baseball in left armpit and very sore. The clinical outcome of the events taste altered, lymphadenopathy axillary and armpit pain were recovered on unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: LISINOPRIL

Current Illness:

ID: 1522245
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Severe body ache; Chills; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0171) via an unspecified route of administration in the left arm on an unknown date (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8729) via an unspecified route of administration in the left arm on 11Apr2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced severe body ache 1 day after the 2nd dose, chills 1 day after the 2nd dose and tiredness during 3 days after the 2nd dose. Therapeutic measures were taken as a result of body ache, chills, tiredness and included treatment with tylenol. The clinical outcome of the events severe body ache, chills and tiredness were all resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1522246
Sex: M
Age:
State: MO

Vax Date: 04/09/2021
Onset Date: 04/23/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Shingles covered left side of forehead, eye, and nose; Shingles covered left side of forehead, eye, and nose; This is a spontaneous report from a contactable consumer (patient). A 38-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in right arm on 09Apr2021 16:00 (Batch/Lot Number: ER8729) as a single dose (at the age of 38 years old) for COVID-19 immunisation. Medical history included overactive bladder. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included oxybutynin (OXYBUTYNIN) taken for an unspecified indication, start and stop date were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received dose 1 of BNT162b2 (at the age of 38 years old) on 19Mar2021 at 4:00 PM (batch/lot number: ER8727) in Right arm. On 23Apr2021, at 06:00 PM, the patient broke out into shingles. Shingles covered left side of forehead, eye, and nose. The event resulted in an Emergency room/department or urgent care visit and the patient received treatment with antiviral medication. The events were reported as non-serious by the patient. The patient was recovering from the shingles. Since the vaccination, has the patient has not been tested for COVID-19.

Other Meds: OXYBUTYNIN

Current Illness:

ID: 1522247
Sex: F
Age:
State: OH

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: increased GI issue; joint inflammation; Sinus issue; weakness in arms and legs; heart palpitations; Migraine; lightheadedness; fatigue; burning at injection site; muscle cramping/soreness/weakness; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8734) in the arm left on 09Apr2021 at 13:00(at the age of 31-year-old) as a dose for COVID-19 immunisation. Medical history included mast cell activation syndrome. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received medications within two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 13:00 the patient experienced weakness in arms, heart palpitation, migraine, light headeness, fatigue and burning at injection site. On 10Apr2021 the patient experienced increased GI and sinus issues and joint inflammation. The patient reported after 5 - 15 minutes of injection: burning at injection site, weakness in arms, heart palpitations. 1 - 2 hours after injection: weakness in arms and legs, heart palpitations, migraine, lightheadedness, fatigue. 5 hours after injection: immense fatigue, muscle cramping/soreness/weakness. Next day (10Apr2021) : increased GI and sinus issues, immense fatigue, muscle weakness, joint inflammation, migraine, lightheadedness. Next 5 days: fatigue and muscle weakness continued. The clinical outcome of the event weakness in arms, heart palpitation, migraine, lightheadedness, burning at injection site increased GI and sinus issues, fatigue and joint inflammation were recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522248
Sex: M
Age:
State: CO

Vax Date: 04/15/2021
Onset Date: 05/03/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Strong episodes of brain fog resembling a marijuana high a couple of days apart; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 15Apr2021 at 16:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. Concomitant medications included PROPECIA from an unknown date for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 04:00, the patient experienced strong episodes of brain fog resembling a marijuana high a couple of days apart. No therapeutic measures were taken as a result of the event. The clinical outcome of the event strong episodes of brain fog resembling a marijuana was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROPECIA

Current Illness:

ID: 1522249
Sex: M
Age:
State: CA

Vax Date: 05/03/2021
Onset Date: 05/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Rash on feet, under right arm, on right side of arm; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the arm left on 03May2021 at 16:15 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 19:45, the patient experienced rash on feet, under right arm, on right side of arm. The clinical outcome of the event rash on feet, under right arm, on right side of arm was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522250
Sex: F
Age:
State: CA

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Dizziness; Drop in heart rate; Extreme tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm left on 12Apr2021 at 12:15(at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included shingles, eczema and blood pressure high. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) and chlortalidone (CHLORTHALIDONE); all from unknown dates for unspecified indication. The patient previously received sulfa (unspecified) on unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 07:00, the patient experienced dizziness, drop in heart rate and extreme tiredness. The clinical outcome of the event dizziness, drop in heart rate, extreme tiredness was recovered on an unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds: ATENOLOL; CHLORTHALIDONE

Current Illness:

ID: 1522251
Sex: F
Age:
State: OH

Vax Date: 04/19/2021
Onset Date: 04/26/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Delayed period by 6 days; Heavy menstrual bleeding; Extended pms symptoms; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169), via an unspecified route of administration in the left arm on 19Apr2021 at 13:00 (at the age of 27-year-old), as a single dose for COVID-19 immunisation. Medical history included tonsillectomy, appendectomy and kidney stones. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (ACETAMINOPHEN) for an unknown indication from an unspecified date. The patient's past drug included nitrofurantoin (MACROBID) for an unknown indication on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021, the patient experienced delayed period by 6 days, heavy menstrual bleeding and extended premenstrual syndrome (PMS) symptoms. The clinical outcome of the event delayed period, bleeding menstrual heavy and premenstrual syndrome was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN; ACETAMINOPHEN

Current Illness:

ID: 1522252
Sex: F
Age:
State: NC

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Flu-like; Aches all over; Red urine; Heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 13:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date in Apr2021 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021, the patient experienced flu-like symptoms, aches all over, red urine and heart palpitations. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events flu-like symptoms, aches all over, red urine and heart palpitations was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522253
Sex: F
Age:
State: CA

Vax Date: 04/24/2021
Onset Date: 05/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Nose bleed today both sides; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 14:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder. Concomitant medications included lithium (MANUFACTURER UNKNOWN) and quetiapine (MANUFACTURER UNKNOWN). The patient had no past drug. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 09:00 the patient experienced nose bleed both sides. The clinical outcome of the event nose bleed both sides was recovering. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LITHIUM; QUETIAPINE

Current Illness:

ID: 1522254
Sex: F
Age:
State: NJ

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Vomiting x 6; nausea; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the arm left on 05May2021 at 14:15 (at the age of 24-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma. The patient was allergic to crab. The patient received unknown birth control within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 02:15 (as mentioned in the source document), the patient experienced vomiting and nausea. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. It was unknown if the patient received any treatment for adverse event. The clinical outcomes of the events vomiting and nausea was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522255
Sex: F
Age:
State: OH

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Tiredness; Soreness in arm; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 03May2021 at 17:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. The patient previously received no medication. The patient received unspecified concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04May2021, the patient experienced tiredness and soreness in arm. The clinical outcome of the events tiredness and soreness in arm was recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522256
Sex: F
Age:
State: MA

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Swollen lymph node under left arm/ in armpit area; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 01May2021 at 11:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other medications within two weeks of vaccination. Past drug included latex. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 10Apr2021 11:15 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01May2021 at 17:00, the patient experienced swollen lymph node under left arm/ in armpit area. The clinical outcome of the event swollen lymph node under left arm/ in armpit area was resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522257
Sex: F
Age:
State: CT

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Sharp stomach pain; Gum bleeding (more than normal).; Minor nose bleed; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 05May2021 at 12:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. No medical history was reported. Concomitant medications included amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL) taken for an unknown indication from an unknown date, escitalopram oxalate (LEXAPRO) taken for an unknown indication from an unknown date and lamotrigine (LAMICTAL) taken for an unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 07Apr2021 at 13:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05May2021, the patient experienced a sharp stomach pain which started within 30 minutes of the vaccine and lasted several hours (at the time of this report), minor nose bleed, gum bleeding (more than normal) when brushing teeth and exhaustion. The clinical outcome of the events sharp stomach pain, gum bleeding, minor nose bleed, exhaustion was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADDERALL; LEXAPRO; LAMICTAL

Current Illness:

ID: 1522258
Sex: M
Age:
State: MI

Vax Date: 04/17/2021
Onset Date: 04/19/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Ringing in the ears that varied in intensity but usually mild; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 17Apr2021 at 13:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high which was normal with medicines and high cholesterol from unknown dates. Concomitant medications included atorvastatin calcium (LIPITOR), esomeprazole (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and losartan (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 26Mar2021 at 13:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19. On 19Apr2021 at 00:00, the patient experienced ringing in the ears that varied in intensity but usually was mild. It was constant and the patient, could hear it through ambient noise (tinnitus). This started only after the second dose. The patient's hearing was still normal otherwise and could hear every sound. The clinical outcome of the event ringing in the ears that varied in intensity but usually mild was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds: LIPITOR; ESOMEPRAZOLE; LOSARTAN; VITAMIN D NOS

Current Illness:

ID: 1522259
Sex: M
Age:
State: NJ

Vax Date: 04/06/2021
Onset Date: 04/08/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Lump in left shoulder at injection site fairly hard and about 3 inches long; Injection site was red.; Injection site was warm; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 09:45 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the arm left on 27Apr2021 at 09:45 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. No medical history was reported. Concomitant medications included lisinopril (LISINOPRIL), acetylsalicylic acid (BABY ASPIRIN) and vitamins nos; minerals nos (CENTRUM) taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021, the patient experienced a lump in left shoulder at injection site which was fairly hard, about 3 inches long and was red and warm. The event resulted in a doctor or other healthcare professional office/clinic visit. The clinical outcome of the event lump in left shoulder at injection site which was fairly hard, about 3 inches long and was red and warm was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; BABY ASPIRIN; Centrum

Current Illness:

ID: 1522260
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 05/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Sweating; Vomiting; Dizziness; Fever; Nausea; Arm pain; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8730) via an unspecified route of administration in the arm left on 05May2021 at 15:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included montelukast sodium (SINGULAIR) and ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN) both taken for unspecified indication from an unknown date. The patient previously took morphine and experienced allergy on an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8737) via an unspecified route of administration in the arm left on 07Apr2021 at 14:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 20:00, the patient experienced sweating, vomiting, dizziness, fever, nausea and pain in arm. The clinical outcome of the events sweating, vomiting, dizziness, fever, nausea and pain in arm were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SINGULAIR; ORTHO TRI-CYCLEN

Current Illness:

ID: 1522261
Sex: F
Age:
State: MA

Vax Date: 05/01/2021
Onset Date: 05/02/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: had significant muscle pain around left shoulder blade; muscle pain even on the side of left body near chest; I had significant muscle pain around my left shoulder blade.; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 01May2021 at 16:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 10Apr2021 at 12:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 02May2021 at 07:30, the patient experienced significant muscle pain around the left shoulder blade and even on the side of the left body near chest. The clinical outcome of the events significant muscle pain around the left shoulder blade and even on the side of the left body near chest was recovered on 03May2021. The patient underwent a lab test on 05May2021 which included nasal swab test and the result was pending. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522262
Sex: F
Age:
State: GA

Vax Date: 04/03/2021
Onset Date: 04/07/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Burnt taste and smell; Burnt taste and smell; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 14:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Mar2021 at 15:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 00:00, the patient experienced burnt taste and smell to everything. The clinical outcome of the events burnt taste and smell to everything was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522263
Sex: F
Age:
State: VA

Vax Date: 04/13/2021
Onset Date: 04/17/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Lymph nodes behind my right ear swelled; Fever; Felt extremely tired; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm right on 13Apr2021 at 11:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes, COPD (Chronic obstructive pulmonary disease), heart disease. The patient received unspecified medication within two weeks of vaccination. The patient previously received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 23Mar2021 at 11:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Apr2021 at 08:00, 4 days post second vaccine, the patient experienced lymph nodes behind her right ear swelled, seemed to run a fever and felt extremely tired for about 24 hours. The lymph nodes remained swollen for 6 days, gradually reducing in size over that time. The clinical outcome of lymph nodes behind right ear swelled was recovered on an unknown date in 2021 and the clinical outcomes of fever, felt extremely tired were recovered on 18Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522264
Sex: F
Age:
State: GA

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Injection site pain; Tired; Headache; Muscle pain; Chills; Feeling unwell; Low back pain; Neck pain; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er 8733) via an unspecified route of administration in the left arm on 05May2021 at 08:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Patient had no medical history. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6207) via an unspecified route of administration in the left arm on 14Apr2021 at 08:45 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 08:45 the patient experienced injection site pain, tired, headache, muscle pain, chills, feeling unwell, low back pain and neck pain. The clinical outcome of the events injection site pain, tired, headache, muscle pain, chills, feeling unwell, low back pain and neck pain was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522265
Sex: U
Age:
State: MO

Vax Date: 04/30/2021
Onset Date: 05/02/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: serious chest pain; neck pain; sore throat; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old patient of unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 30Apr2021 at 11:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis rheumatoid. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 09Apr2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received penicillin (MANUFACTURER UNKNOWN) from unknown date for unspecified indication and unknown if ongoing. Since the vaccination, the patient was tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, 2 days after 2nd vaccine, the patient experienced serious chest pain neck pain and sore throat. It had been 7 days and the patient still had these symptoms. On an unknown date, the patient underwent nasal swab and the result was negative. The clinical outcome of the event serious chest pain, neck pain and sore throat was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522266
Sex: F
Age:
State: CA

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Injection site pain; swelling; Body aches; Fever; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 05May2021 at 10:45 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took sulfa. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 14Apr2021 at 12:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 20:00, the patient experienced injection site pain, swelling, body aches, fever, nausea and fatigue. The clinical outcome of the events injection site pain, swelling, body aches, fever, nausea and fatigue were not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522267
Sex: F
Age:
State: CA

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Extremely itchy rash/eczema on both armpits spreading down towards torso; Extremely itchy rash/eczema on both armpits spreading down towards torso; Stomach ache; Vomiting; Diarrhea; Fever; Body aches; Chills; Stiff neck; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Apr2021 at 09:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Concomitant medications included probiotics (MANUFACTURER UNKNOWN). The patient previously took tetracycline, doxycycline, minocycline, Z-PAK and experienced drug allergy with all of these. On 17Mar2021, the patient received an allergy shot (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Apr2021 at 03:30, the patient experienced extremely itchy rash/eczema on both armpits spreading down towards torso, stomach ache, vomiting, diarrhea, fever, body aches, chills, stiff neck and nausea. The events resulted in a visit to the doctors or other healthcare professional office/clinic visit. Therapeutic measure was taken as a result of the event itchy rash/eczema and included treatment with steroid cream. The clinical outcome of the events extremely itchy rash/eczema on both armpits spreading down towards torso, stomach ache, vomiting, diarrhea, fever, body aches, chills, stiff neck and nausea were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm